JNJ Johnson & Johnson

Price (delayed)

$178.88

Market cap

$467.68B

P/E Ratio

24.5

Dividend/share

$4.45

EPS

$7.3

Enterprise value

$488.35B

Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceutical, and consumer packaged goods. Its common stock is a component of the Dow Jones ...

Highlights
The EPS has grown by 8% YoY and by 4.4% from the previous quarter
Johnson & Johnson's net income has increased by 7% YoY and by 4.3% QoQ
JNJ's price to earnings (P/E) is 65% lower than its 5-year quarterly average of 70.8 but 5% higher than its last 4 quarters average of 23.3
JNJ's equity is up by 6% year-on-year but it is down by 2.3% since the previous quarter

Key stats

What are the main financial stats of JNJ
Market
Shares outstanding
2.61B
Market cap
$467.68B
Enterprise value
$488.35B
Valuations
Price to earnings (P/E)
24.5
Price to book (P/B)
6.3
Price to sales (P/S)
4.89
EV/EBIT
21.69
EV/EBITDA
16.52
EV/Sales
5.08
Earnings
Revenue
$96.04B
EBIT
$22.52B
EBITDA
$29.56B
Free cash flow
$17.74B
Per share
EPS
$7.3
Free cash flow per share
$6.75
Book value per share
$28.37
Revenue per share
$36.55
TBVPS
$38.59
Balance sheet
Total assets
$175.12B
Total liabilities
$100.53B
Debt
$32.03B
Equity
$74.6B
Working capital
$19.69B
Liquidity
Debt to equity
0.43
Current ratio
1.43
Quick ratio
1.1
Net debt/EBITDA
0.7
Margins
EBITDA margin
30.8%
Gross margin
67.4%
Net margin
19.9%
Operating margin
23.9%
Efficiency
Return on assets
10.7%
Return on equity
25.6%
Return on invested capital
29.3%
Return on capital employed
17.4%
Return on sales
23.4%
Dividend
Dividend yield
2.49%
DPS
$4.45
Payout ratio
61%

JNJ stock price

How has the Johnson & Johnson stock price performed over time
Intraday
0.08%
1 week
0.93%
1 month
4.96%
1 year
13.87%
YTD
4.57%
QTD
9.5%

Financial performance

How have Johnson & Johnson's revenue and profit performed over time
Revenue
$96.04B
Gross profit
$64.76B
Operating income
$22.94B
Net income
$19.16B
Gross margin
67.4%
Net margin
19.9%
Johnson & Johnson's net income has increased by 7% YoY and by 4.3% QoQ
JNJ's revenue is up by 5% year-on-year
The gross profit is up by 4.9% YoY
Johnson & Johnson's net margin has increased by 3.6% from the previous quarter

Growth

What is Johnson & Johnson's growth rate over time

Valuation

What is Johnson & Johnson stock price valuation
P/E
24.5
P/B
6.3
P/S
4.89
EV/EBIT
21.69
EV/EBITDA
16.52
EV/Sales
5.08
JNJ's price to earnings (P/E) is 65% lower than its 5-year quarterly average of 70.8 but 5% higher than its last 4 quarters average of 23.3
The EPS has grown by 8% YoY and by 4.4% from the previous quarter
JNJ's equity is up by 6% year-on-year but it is down by 2.3% since the previous quarter
JNJ's price to book (P/B) is 5% more than its 5-year quarterly average of 6.0 and 3.3% more than its last 4 quarters average of 6.1
The price to sales (P/S) is 6% more than the 5-year quarterly average of 4.6
JNJ's revenue is up by 5% year-on-year

Efficiency

How efficient is Johnson & Johnson business performance
The ROS has grown by 9% from the previous quarter and by 8% YoY
Johnson & Johnson's return on invested capital has increased by 7% QoQ
The return on assets has increased by 4.9% since the previous quarter and by 4.9% year-on-year
The company's return on equity fell by 3.8% YoY but it rose by 2.8% QoQ

Dividends

What is JNJ's dividend history
DPS
$4.45
Dividend yield
2.49%
Payout ratio
61%
Recent dividends

Financial health

How did Johnson & Johnson financials performed over time
JNJ's total assets is 74% greater than its total liabilities
Johnson & Johnson's total liabilities has decreased by 8% YoY
JNJ's current ratio is up by 7% year-on-year
Johnson & Johnson's debt is 57% less than its equity
The company's debt to equity fell by 10% YoY
JNJ's equity is up by 6% year-on-year but it is down by 2.3% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.